(97) It has been proposed that neurotoxicity may reflect an on-target, off-tumor effect of anti-CD19 CAR T cell therapy given that CD19 expression was observed by single-cell RNA sequencing analysis of human brain mural cells, which support the vasculature. This evidence concerns the gene CD19 and neoplasm.